Ríos-Lugo MJ,
Martin C, Alarcón JA, Esquifino
A, Barbieri G, Solano P, Sanz
M. Optimization of buffer solutions to analyze
inflammatory cytokines in gingival crevicular fluid
by multiplex flow cytometry. Med Oral Patol
Oral Cir Bucal. 2015 Jan 1;20
(1):e13-6.
doi:10.4317/medoral.19852
http://dx.doi.org/doi:10.4317/medoral.19852
1. Dutzan
N, Vernal R, Hernandez M, Dezerega
A, Rivera O, Silva N, et al. Levels of interferon-gamma and transcription
factor T-bet in progressive
periodontal lesions in patients with chronic periodontitis. J Periodontol.
2009;80:290-6. |
|
|
|
2. Garlet
GP, Martins W, Ferreira BR, Milanezi
CM, Silva JS. Patterns of chemokines
and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003;38:210-7. |
|
|
|
3. Shaddox
LM, Wiedey J, Calderon
NL, Magnusson I, Bimstein
E, Bidwell JA, et al. Local inflammatory
markers and systemic endotoxin in aggressive
periodontitis. J Dent Res. 2011;90:1140-4. |
|
|
|
4. Wöstmann
B, Rehmann P, Balkenhol
M. Influence of different retraction techniques on crevicular
fluid flow. Int J Prosthodont.
2008;21:215-6. |
|
|
|
5. Turk B, Turk D, Salvesen GS. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des. 2002;8:1623-37. |
|
|
|
6. Guentsch
A, Kramesberger M, Sroka
A, Pfister W, Potempa J, Eick S. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic
periodontitis. J Periodontol. 2011;82:1051-60. |
|
|
|
7. Ciantar
M, Caruana DJ. Periotron
8000: calibration characteristics
and reliability. J Periodontal
Res. 1998;33:259-64. |
|
|
|
8. Griffiths
GS. Formation, collection
and significance of gingival crevice
fluid. Periodontol 2000. 2003;31:32-42. |
|
|
|
9. Doble P, Macka
M, Haddad PR. Factors influencing the choice of buffer in background electrolytes for indirect detection of fast anions by
capillary electrophoresis.
Electrophoresis. 1998;19:2257-61. |
|
|
|
10. Gómez G, Pikal
MJ, Rodríguez-Hornedo N. Effect
of initial buffer composition
on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions. Pharm Res. 2001;18:90-7. |
|
|
|
11. Wadhwa
M, Thorpe R. Cytokine immunoassays: recommendations for standardisation, calibration and validation. J Immunol Methods. 1998;219:1-5. |
|
|
|
12. Mire-Sluis
AR, Gaines-Das R, Thorpe
R. Immunoassays for detecting cytokines: what are they really measuring?. J Immunol Methods.
1995;186:157-60. |
|
|
|
13. Findlay JW, Smith WC, Lee JW, Nordblom GD, Das I, DeSilva BS,
et al. Validation of immunoassays
for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000;21:1249-73. |
|
|
|
14. Mire-Sluis
AR, Barrett YC, Devanarayan
V, Koren E, Liu H, Maia M, et al. Recommendations for the design
and optimization of immunoassays
used in the detection of host antibodies against biotechnology products. J Immunol Methods. 2004;289:1-16. |
|
|
|
15. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson
EL. Validation and comparison
of luminex multiplex cytokine
analysis kits with ELISA:
determinations of a panel of nine
cytokines in clinical sample culture supernatants. J Reprod Immunol. 2005;66:175-91. |
|
|